Han Chong Toh Selected Research

Han Chong Toh Research Topics

Disease

49	Neoplasms (Cancer) 04/2024 - 07/2003
29	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 07/2008
6	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 12/2009
5	Liver Neoplasms (Liver Cancer) 01/2023 - 01/2019
4	Melanoma (Melanoma, Malignant) 11/2020 - 12/2009
4	Stomach Neoplasms (Stomach Cancer) 05/2012 - 01/2007
3	Nasopharyngeal Carcinoma 04/2024 - 01/2021
3	Carcinoma (Carcinomatosis) 11/2020 - 01/2013
3	Carcinogenesis 09/2020 - 01/2019
2	Adenocarcinoma 10/2022 - 01/2010
2	Peritoneal Neoplasms 02/2017 - 01/2013
2	Breast Neoplasms (Breast Cancer) 08/2014 - 05/2012
1	Oncogene Addiction 04/2024
1	Fatty Liver 04/2024
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2023
1	Obesity 01/2023
1	Hypoxia (Hypoxemia) 11/2022
1	Inflammation (Inflammations) 01/2022
1	Exanthema (Rash) 12/2021
1	Fibrosis (Cirrhosis) 12/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 11/2020
1	Experimental Liver Neoplasms 01/2020
1	Hand-Foot Syndrome 11/2017
1	Disease Progression 02/2017
1	Nasopharyngeal Neoplasms (Cancer of the Nasopharynx) 04/2016
1	Non-Muscle Invasive Bladder Neoplasms 01/2016

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
8	Immune Checkpoint InhibitorsIBA 04/2024 - 04/2016
6	Sorafenib (BAY 43-9006)FDA Link 12/2022 - 01/2010
6	Proteins (Proteins, Gene)FDA Link 10/2022 - 07/2008
5	Bevacizumab (Avastin)FDA Link 12/2022 - 07/2008
5	AntigensIBA 10/2022 - 09/2009
4	LigandsIBA 12/2023 - 03/2012
4	RNA (Ribonucleic Acid)IBA 03/2022 - 02/2017
4	Capecitabine (Xeloda)FDA Link 11/2017 - 01/2007
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2023 - 10/2012
3	atezolizumabIBA 12/2022 - 01/2022
3	ChemokinesIBA 11/2022 - 03/2012
3	VaccinesIBA 10/2022 - 12/2009
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 07/2008
3	Gemcitabine FDA Link 06/2021 - 07/2008
3	CytokinesIBA 01/2021 - 03/2012
3	Sirolimus (Rapamycin)FDA Link 01/2010 - 07/2008
3	TOR Serine-Threonine KinasesIBA 09/2009 - 07/2008
2	NivolumabIBA 01/2023 - 12/2021
2	CD40 Ligand (CD40L)IBA 10/2022 - 08/2014
2	EnzymesIBA 09/2020 - 01/2019
2	Toll-Like Receptor 3IBA 12/2012 - 03/2012
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2012 - 01/2007
2	XELOXIBA 07/2012 - 01/2007
2	Thalidomide (Thalomid)FDA Link 06/2011 - 01/2010
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 04/2024
1	Antiviral Agents (Antivirals)IBA 04/2024
1	Programmed Cell Death 1 ReceptorIBA 12/2023
1	Trefoil Factor-3IBA 01/2023
1	Interferon-gamma (Interferon, gamma)IBA 01/2023
1	LipidsIBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 11/2022
1	Granzymes (Granzyme)IBA 11/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2022
1	SirtuinsIBA 01/2022
1	Cytidine Triphosphate (CTP)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021
1	Alanine Transaminase (SGPT)IBA 12/2021
1	BilirubinIBA 12/2021
1	InflammasomesIBA 06/2021
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 06/2021
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2021
1	pembrolizumabIBA 01/2021
1	Janus Kinase 2IBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Oncogene Proteins (Oncogene Protein)IBA 01/2021
1	Combined VaccinesIBA 11/2020
1	Cancer VaccinesIBA 11/2020
1	GuanosineIBA 09/2020
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 09/2020
1	Oxidoreductases (Dehydrogenase)IBA 09/2020
1	NucleosidesIBA 09/2020
1	purineIBA 09/2020
1	Messenger RNA (mRNA)IBA 06/2020
1	Zoledronic Acid (Zometa)FDA Link 06/2020
1	Proline (L-Proline)FDA Link 01/2020
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020
1	Intergenic DNA (Junk DNA)IBA 01/2019
1	Branched-Chain Amino AcidsIBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2019
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2019
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 11/2017
1	Epithelial Cell Adhesion MoleculeIBA 02/2017
1	EpitopesIBA 04/2016
1	acylcarnitineIBA 02/2016

Therapy/Procedure

28	Therapeutics 04/2024 - 01/2006
17	Immunotherapy 04/2024 - 05/2012
11	Drug Therapy (Chemotherapy) 01/2021 - 07/2003
2	Microspheres (Microsphere) 01/2023 - 12/2021
2	Radiotherapy 01/2022 - 12/2021
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021 - 11/2020
1	Transplantation 01/2023
1	Injections 11/2020